NCBiotech News

We work hard to bring you the stories about the life science community in North Carolina. Every once in a while, we add a little news of our own. Read some of those stories below, or check out some of our perspectives on our staff blog.

When Nancy Rosborough read an article in the Washington Post about growing truffles, a gourmet delicacy that’s normally harvested from the wild, the novel idea took root as a Burlington biotech company.

Seventeen bioscience companies that previously received funding from the North Carolina Biotechnology Center raised nearly $11 million in follow-on funding from other sources in the second quarter of the 2016-17 fiscal year that ended Dec. 31.

The North Carolina Biotechnology Center awarded 13 grants and loans totaling $1.4 million to universities and bioscience companies in the second quarter of its 2016-2017 fiscal year ending Dec. 31.

Raleigh bioscience startup Locus Biosciences, a spinout of North Carolina State University, is using a version of the hot gene-editing technology called CRISPR to cut a new path to the discovery and development of novel antibiotics.

It was a gray afternoon in March, 2008 at the North Carolina Biotechnology Center. A kindly looking gentleman stood in our Congressional Room, surrounded by a group of North Carolina’s brightest young scientists, winners of various science competitions across the state that year.

Two former commissioners of the U.S. Food and Drug Administration, both with ties to Duke University, are among the speakers headlining the Council for Entrepreneurial Development’s 26th annual Life Science Conference in Raleigh Feb. 28 and March 1.

Oliver Smithies, D.Phil., who was recruited to North Carolina with grant funding from the North Carolina Biotechnology Center and won the Nobel Prize in Physiology or Medicine 20 years later, died today at the age of 91.

G1 Therapeutics, a clinical-stage oncology company based in Research Triangle Park, is expanding its search for new anti-cancer weapons by launching three more clinical trials targeting breast cancer.

Winter weather over the weekend brought treacherous road conditions to much of North Carolina. The Biotech Center's offices have adjusted their hours accordingly:

  • Eastern Office (Greenville) - closed
  • Greater Charlotte Office - closed
  • Piedmont Triad Office (Winston-Salem) - closed
  • Research Triangle Park headquarters - closed

Don't worry - Team NCBiotech is still working, and most of us can be reached by email.

Updated (:48 a.m. 1/9/2017

Durham-based Viamet Pharmaceuticals has reported positive results from clinical trials of its lead product candidate for the treatment of two common fungal infections.

Durham’s GeneCentric Diagnostics has received an undisclosed sum of equity funding for a biomarker research collaboration with pharmaceutical giant Bristol-Myers Squibb.

Cohera Medical Inc., a medical-device company that relocated to Raleigh from Pittsburgh a year ago, has enrolled the first patient in a clinical trial of its Sylys Surgical Sealant.

Discovering the key ingredients in the Research Triangle’s ecosystem has become one of the great quests in economic development.

Humacyte, a regenerative medicine company based in Morrisville, has launched a Phase 2 clinical trial of Humacyl, its bioengineered blood vessel, in patients with peripheral arterial disease.

RAUMEDIC, a family-owned German company, is nearing its first anniversary at its $27 million development and production facility in western North Carolina.